Recent changes in clinical guidelines and data availability have expanded the options for developing quality measures that include stroke severity assessment. 6 Assessment of the Background and Purpose-The Centers for Medicare & Medicaid Services publicly reports a hospital-level stroke mortality measure that lacks stroke severity risk adjustment. Our objective was to describe novel measures of stroke mortality suitable for public reporting that incorporate stroke severity into risk adjustment. Methods-We linked data from the American Heart Association/American Stroke Association Get With The GuidelinesStroke registry with Medicare fee-for-service claims data to develop the measures. We used logistic regression for variable selection in risk model development. We developed 3 risk-standardized mortality models for patients with acute ischemic stroke, all of which include the National Institutes of Health Stroke Scale score: one that includes other risk variables derived only from claims data (claims model); one that includes other risk variables derived from claims and clinical variables that could be obtained from electronic health record data (hybrid model); and one that includes other risk variables that could be derived only from electronic health record data (electronic health record model). Results-The cohort used to develop and validate the risk models consisted of 188 975 hospital admissions at 1511 hospitals.
A s part of national efforts to improve the quality of care for patients with stroke, the Centers for Medicare & Medicaid Services (CMS) publicly reports hospital results on a 30-day stroke mortality measure in the Inpatient Quality Reporting program. The current publicly reported stroke mortality measure is calculated using purely administrative claims data and does not directly risk adjust for stroke severity at initial presentation. 1 Clinicians and other stakeholders have long called for including an assessment of stroke severity-a strong predictor of mortality [2] [3] [4] -in risk-adjustment models of stroke mortality 5 used to profile hospital quality for patients with ischemic stroke. However, no national data source for this information existed that could be incorporated into nationally reported quality measures.
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National Institutes of Health Stroke Scale (NIHSS), a 15-item neurological examination used to provide a quantitative measure of stroke-related neurological deficit, for patients with acute ischemic stroke on presentation is now a class I recommendation in the American Heart Association/American Stroke Association (AHA/ASA) guidelines. 7 In addition, the NIHSS was added to the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) in October 2016, meaning it can be captured in claims data if submitted. Finally, the widespread adoption of electronic health records (EHRs) by hospitals opens the possibility of national measures of stroke mortality incorporating stroke severity assessment extracted from the EHR.
Our aim was to develop and compare 3 new performance measures of hospital-level mortality for patients admitted to the hospital with acute ischemic stroke intended for assessment of hospital quality that include the NIHSS in the riskadjustment models: a claims-only model that incorporates the ICD-9-CM codes for comorbidities and the NIHSS, a hybrid model that could be implemented using claims and EHR data, and an EHR model that uses only data elements feasibly extracted from the EHR, including the NIHSS. The goal was to develop quality measures that (1) improve on the existing publicly reported stroke mortality measure by incorporating an assessment of stroke severity that would be suitable for national public reporting and (2) provide implementation options for distinct data sources.
Methods
We developed 3 hospital-level 30-day ischemic stroke mortality risk models, all with the same cohort, but each intended for use with distinct data sources for risk adjustment: a measure with a risk model that included variables available only using claims data, including the NIHSS (claims model); a measure with a risk model that included the NIHSS and other variables available in claims data plus clinical variables that will be extracted from the EHR, including vital signs and basic laboratory results (hybrid model); and a measure with a risk model that included the NIHSS and clinical variables that will be extracted only from clinical EHR data (EHR model). Because the NIHSS was not available in national claims or EHR data at the time of measure development, we used data from the AHA/ASA's Get With The Guidelines-Stroke (GWTG-Stroke) registry for development and validation as a surrogate for NIHSS and clinical variables that would be obtained from claims or EHR. For measure development, we used 2 existing sources of national data on patients with acute ischemic stroke: Medicare fee-for-service administrative claims and the AHA/ASA GWTG-Stroke registry. To create the data set for measure development and validation, these 2 data sources were linked using provider identification number (ID), patient age on admission, sex, admission date, and discharge date. We selected clinical risk variables from registry data that can be feasibly extracted from the EHR for future implementation. Further, since this work began, CMS has added an administrative claims ICD-10-CM diagnosis code for the NIHSS, allowing for future implementation of a claims-based measure that includes the NIHSS. We refer to the measures based on their intended data source for future implementation. Below we describe the data sources, cohort derivation, outcome definition, and statistical approach.
The Yale University Human Investigation Committee accepted a waiver of consent and approved this analysis.
Data Sources
There is no currently available national source of multihospital EHR data that includes both the NIHSS and a wide range of clinical factors. Therefore, we used 2 existing sources of national data on patients with acute ischemic stroke: Medicare fee-for-service administrative claims and the AHA/ASA GWTG-Stroke registry. The AHA/ASA's GWTG-Stroke registry data were used as surrogate data for both the NIHSS and clinical data elements that would be extracted from the EHR if the measures were implemented. We only considered a limited set of registry data elements for use in the measure, based on whether they could be feasibly extracted from EHRs, as indicated by previous study. 8, 9 These data sources were linked to create the data set used for measure development and validation. We randomly split the study cohort into 2 parts; half of the study cohort was used to develop the risk-adjustment models and the other half was used for validation of the models.
Administrative claims data on patients with an inpatient admission for ischemic stroke between July 1, 2011 5 which includes the following information on patients with ischemic stroke collected using the GWTG-Stroke Patient Management Tool: patient characteristics such as age and sex; arrival and admission information; medical history (such as atrial fibrillation/flutter, previous stroke/transient ischemic attack, previous myocardial infarction, diabetes mellitus, and hypertension and heart failure); clinical diagnoses; medications before admission; measurements (such as total cholesterol, triglycerides, HDL [high-density lipoprotein], LDL [low-density lipoprotein], blood glucose, serum creatinine, international normalized ratio, heart rate, blood pressure, and weight); and the NIHSS score used to evaluate the effect of acute ischemic stroke on the levels of sensory loss, dysarthria, ataxia, motor strength, extraocular movement, visual field loss, neglect, language, and consciousness. The AHA/ASA uses a number of strategies to ensure that data submitted to the GWTGStroke Registry are complete, consistent, and accurate. 10 
Cohort Derivation
We derived the cohort for measure development and validation by deterministically matching admissions for stroke included in the GWTG-Stroke Registry with admissions for ischemic stroke in the Medicare claims data set discharged in the same time period ( Figure  I in the online-only Data Supplement). In the claims data set, we identified discharges with ischemic stroke by ICD-9-CM principal discharge diagnosis codes 433.01, 433.11, 433.21, 433.31, 433.81, 433.91, 434.01, 434.11, 434.91, and 436. In the GWTG-Stroke Registry data set, stroke was identified clinically through chart abstraction.
To obtain a comparable cohort of stroke hospitalizations in each data set in preparation for deterministic matching, we excluded the following: patients under the age of 64 years at the time of admission; non-Medicare patients; patients without a principle discharge diagnosis of ischemic stroke (in the Medicare claims data set only); index admissions missing a provider ID; duplicate admissions within each separate data set (admissions for patients who had identical information for age, sex, admission date, discharge date, and provider ID); and cases from facilities with unmatched provider IDs. These initial exclusions before matching were purposefully broader than our intended cohort to maximize the number of matched patients. Then we deterministically matched the remaining hospitalizations using the provider ID, patient age (within 1 year), sex, admission date, and discharge date as the linking fields. Admissions that did not match on all 5 linking fields were excluded ( Figure I in the online-only Data Supplement).
After performing the deterministic match, we applied exclusion criteria similar to those used in the current publicly reported claims-based stroke mortality measure, 1 which removed admissions for patients who were discharged against medical advice; aged <65 years; transferred in from another acute care facility where they had been admitted; who were not enrolled in both part A and part B Medicare for the 12 months before the date of admission, or in part A during the index admission; and with inconsistent or missing vital status. For patients with multiple admissions in a given year, one of them was randomly selected for inclusion in the cohort. For transfer patients (admitted to one acute care facility and then transferred to another hospital), consistent with what is done in the publicly reported measure of stroke mortality, the measure assigns the mortality outcome to the first admitting hospital because the first hospital initiates patient management and is responsible for any decision to transfer the patient.
1
Outcome Definition
Medicare enrollment and inpatient claims data were used to define the outcome, which was 30-day all-cause mortality, defined as death from any cause within 30 days of the index admission date.
Statistical Approach
We developed the risk-adjustment models consistent with the standards articulated in the AHA's scientific statement, "Standards for Statistical Models Used for Public Reporting of Health Outcomes" 11 and with the current CMS publically reported 30-day hospital risk-standardized mortality measures for stroke and other clinical conditions.
Risk Variable Selection
We developed 3 separate risk-adjustment models (claims, hybrid, and EHR) that included the NIHSS and other key variables available at patient presentation deemed clinically relevant and that demonstrated a strong statistical association with 30-day mortality. For the claims and hybrid risk models, we considered all 41 risk-adjustment variables in the current publicly reported claims-based measure as candidate variables, plus the NIHSS (Table I in the online-only Data Supplement). The NIHSS scores obtained from the registry data were used as surrogates for data that are available using claims since October 2016.
To select candidate electronic clinical variables (variable that will be obtained from the EHR when the measure is in use), we first limited the variables considered to the list of clinical variables available in the GWTG-Stroke registry database. We first excluded variables pertaining to postadmission events, such as treatments, complications, and postadmission laboratories, which are not suitable for use in a risk model used to profile hospital quality. Next, we systematically applied 3 exclusion criteria to the remaining data elements to identify variables appropriate for inclusion in the measure and that could be extracted from EHR for measure implementation. We excluded the following: (1) variables unrelated to the patient's clinical status at the time of admission; (2) variables inconsistently or not reliably collected on all patients with stroke; and (3) variables not known to be reliably and feasibly extracted from most EHRs (Table  II in the online-only Data Supplement). This resulted in 14 candidate electronic clinical variables, including the NIHSS, for building the hybrid and EHR models.
Next, we examined the distributions of these 14 candidate electronic clinical variables. We performed multiple imputation (described in detail in Missing Data" section of this article) to replace missing variables. Associations between all continuous clinical variables and mortality were visually inspected with bivariate plots to assess predictive relationships. Then to reduce the effect of spurious outliers, we winsorized variable values to specific ranges based on examination of the distributions of the variables, the predictive relationship between the clinical variable and mortality, clinical suggestions, and previous experience. 12, 13 To select the final risk model for all 3 measures, we performed a bootstrap simulation with 1000 iterations for variable selection among the candidate variables for that measure, using a logistic regression model with stepwise selection (allowed entry for variables with P<0.05; retained variables with P<0.01). We retained all riskadjustment variables selected in >90% of the iterations, demonstrating a consistently strong association with mortality. After bootstrap simulation, if the quadratic version of the variable reached the 90% selected rate, we included both the linear and quadratic versions in the model.
Missing Data
We imputed missing NIHSS values using the standard statistical method of multiple imputation based on patients' comorbidities derived from the claims data, and we used full conditional specification with a multilogit regression model for the imputation. For the hybrid and EHR measures, we used full conditional specification with a linear regression model for the laboratory values and we used a multilogit regression model for the NIHSS in the multiple imputation technique to impute the missing values. We produced 5 copies of imputation data sets for the analyses. The results based on these imputed data were aggregated according to the standard statistical methods for presentation of the results and for the measure score calculation.
14,15
Model Performance and Validation
We randomly split the cohort into 2 parts, one part was used to develop the models (derivation cohort) and the other was used for validate the models (validation cohort). We computed the following summary statistics for assessing final model performance: overfitting indices; predictive ability; area under the receiver operating characteristic curve; distribution of residuals; and model χ 2 in the derivation and validation cohorts separately.
Calculation of Hospital-Specific Risk-Standardized Mortality Rate
We used hierarchical logistic regression models with the selected risk factors as independent variables, and mortality as the dependent variable, along with a hospital-specific random effect to account for the natural clustering of observations within hospitals. 16 With the hierarchical logistic regression models, we calculated hospital-specific risk-standardized mortality rates (RSMRs) as the ratio of predicted number of deaths to expected number of deaths, multiplied by the national unadjusted mortality rate. We used the same method to estimate the predicted and expected number of deaths in each hospital as was used in the publicly reported measure of stroke mortality. 
Measure Score Reliability
We calculated the RSMRs separately for each of the 3 models in the derivation and validation cohorts and examined the measure score reliability using the intraclass correlation.
Correlation of Measure Scores
We calculated the RSMRs separately for each of the 3 models and for the current publicly reported measure in the study cohorts and examined the correlation of the measure scores using the hospital-volume weighted Pearson correlation coefficients.
Results
Cohort Characteristics
The final index cohort consisted of 188 975 acute ischemic stroke hospital admissions at 1511 hospitals ( Figure I 
Stroke
November 2017
were no missing values for risk factors in the claims data; the missing rates for considered laboratory values ranged from 20% to 30%; and there was a 23% rate of missing NIHSS scores. Table 1 compares selected patient characteristics in the GWTG-Stroke registry data for patients matched and unmated to CMS data. Admissions in the claims data that matched to the GWTG-Stroke data as compared with unmated patients were older; slightly less likely to be men; less likely to have comorbidities including cerebral hemorrhage, previous ischemic or unspecified stroke, precerebral arterial occlusion and transient cerebral ischemia, cerebral atherosclerosis and aneurysm, and hemiplegia/hemiparesis; and more likely to have previous valvular and rheumatic heart disease, congenital cardiac/circulatory defects, and heart arrhythmias (all P<0.05).
Model and Measure Performance and Validation
Claims Risk Model
The final logistic regression model included 19 risk-adjustment variables from claims data and the NIHSS. The variable descriptions, estimates, SEs, and odds ratios for the final logistic regression model and for the final hierarchical logistic regression model in the development cohort are shown in Tables III and IV in the online-only Data Supplement, respectively. In the final hierarchical logistic regression model, the estimated mean between-hospital variance in the log-odds of mortality was 0.042 (SE, 0.007); this result implies that the odds of mortality for a high-mortality hospital (+1 SD) were 1.51 times that for a low-mortality hospital (−1 SD). After adjusting for patient characteristics and clustering within hospitals, RSMRs at the hospital level were normally distributed, ranging from 10.75% to 18.98%. The median (interquartile range) RSMR was 14.48% (13.52% to 15.56%; Figure II in the online-only Data Supplement). Both the development and validation models exhibited strong discrimination, calibration, and fit (Table 2 ). Predictive ability was also similar across samples. The C statistic was 0.81 in the development cohort and 0.82 in the validation cohort.
Hybrid Risk Model
The final logistic regression model included 21 risk-adjustment variables, including the NIHSS. The variable descriptions, estimates, SEs, and odds ratios for the final logistic regression model and for the final hierarchical logistic regression model in the development cohort are shown in Tables V and VI in the online-only Data Supplement, respectively. In the final hierarchical logistic regression model, the estimated mean between-hospital variance in the log-odds of mortality was 0.043 (SE, 0.007); this result implies that the odds of mortality for a high-mortality hospital (+1 SD) were 1.52 times that for a low-mortality hospital (−1 SD). After adjusting for patient characteristics and clustering within hospitals, RSMRs at the hospital level were normally distributed, ranging from 10.67% to 19.15%. The median (interquartile range) RSMR was 14.50% (13.50% to 15.61%; Figure III in the onlineonly Data Supplement). Both the development and validation models exhibited strong discrimination, calibration, and fit (Table 3 ). Predictive ability was also similar across datasets. The C statistic was 0.82 in both cohorts. 
EHR Risk Model
The final logistic regression model included 9 risk-adjustment variables, including the NIHSS. The variable descriptions, estimates, SEs, and odds ratios for the final logistic regression model and for the final hierarchical logistic regression model in the development cohort are shown in Tables VII and VIII in the online-only Data Supplement, respectively. In the final hierarchical logistic regression model, the estimated mean between-hospital variance in the log-odds of mortality was 0.043 (SE, 0.007); this result implies that the odds of mortality for a high-mortality hospital (+1 SD) were 1.52 times that for a low-mortality hospital (−1 SD). After adjusting for patient characteristics and clustering within hospitals, RSMRs at the hospital level were normally distributed, ranging from 10.77% to 20.26%. The median (interquartile range) RSMR was 14.46% (13.54% to 15.64%; Figure IV in the online-only Data Supplement). Both the development and validation models exhibited strong discrimination, calibration, and fit (Table 4) . Predictive ability was also similar across data sets. The C statistic was 0.79 and 0.80 in the development and validation cohorts, respectively.
Correlation of RSMRs Among the Models
The Pearson correlation of the standardized rates between those from the claims model and the EHR model was 0.96, between the claims model and the hybrid model was 0.99, between the EHR model and the hybrid model was 0.96, between the current publicly reported measure and the claims model was 0.91, between the current publicly reported measure and the EHR model was 0.88, and between the current publicly reported measure and the hybrid model was 0.90.
Discussion
This article describes the development and comparison of 3 measures of hospital 30-day all-cause risk-standardized ischemic stroke mortality that risk-adjust for stroke severity. Amid the increasing use of hospital EHRs and evolving data collection and extraction techniques, we created 3 different measures that could be implemented in diverse settings depending on the availability of data sources, as well as providers' and payers' preferences. These new risk models have similar model performance, produce similar estimates of hospitallevel RSMRs, and demonstrate better discrimination than that of the current publicly reported hospital-level 30-day stroke mortality measure, which has a C statistic of 0.75 and includes 41 (2 demographic and 39 comorbidity) risk-adjustment variables. There has long been a preference to incorporate stroke severity on presentation into mortality quality measures to improve the face validity of such measures, but previously this has not been feasible because of limitations in national data sources. Recent changes in clinical guidelines supporting documentation of the NIHSS on all patients admitted to the hospital with acute ischemic stroke, updates to administrative codes available to document stroke severity, and the widespread implementation of hospital EHRs create an opportunity to improve on current risk models and implement new models broadly. Our risk models using national data have performance properties similar to previous published models, which have demonstrated that the addition of a stroke severity score or clinical data improve the ability to predict mortality in patients with stroke. For example, using GWTG-Stroke registry data to develop prediction models for a patient's risk of in-hospital ischemic stroke mortality, Smith et al 4 showed that a model with patients' NIHSS scores had better discrimination in predicting a patient's risk of mortality compared with a model that did not include the NIHSS. Similarly, Fonarow et al 2 demonstrated that a claims-based hospital mortality risk model with NIHSS scores substantially outperformed a claims-based model without NIHSS (C statistic 0.86 versus 0.77, respectively; P<0.001).
Given the comparability of model performance and hospital results, these new measures that use distinct data sources provide payers with options about the preferred and most feasible approach to implementation of a stroke mortality measure that includes an assessment of stroke severity. For example, the newly developed claims measure could be implemented as soon as sufficient ICD-10-CM data are available for measure calculation; the existing claims-based measure uses 3 years of data to achieve stable hospital performance estimates. Given the widespread hospital adoption of EHRs, 17 an opportunity exists to move toward the use of the hybrid model or EHR model measures, which will be increasingly feasible in EHRs that incorporate a structured field for NIHSS scores.
This study presents a model for the ongoing evolution and improvement of quality measures. As providers increasingly use EHRs, as data extraction techniques are standardized and novel data elements are more readily available, and as clinical practice and guidelines incorporate new patient assessments, the field of quality measurement will continue to advance in parallel. Ideally, new measures will improve on existing measures, maintaining aligned specifications where appropriate. The success of this evolution will depend on the use of data elements, such as the NIHSS, that have widespread use and acceptability as a clinical standard. 6 In the next phase of this evolution, more consistent collection of NIHSS scores is necessary for these measures to be successfully implemented and ultimately drive improvements in quality of care for patients with stroke across hospitals.
There are limitations to our methodology. First, the GWTGStroke registry is voluntary. Thus, performance of the models for hospitals that do not participate is unknown although previous studies have shown that Medicare beneficiary characteristics are similar between participating and nonparticipating hospitals. 18 Second, because of missing NIHSS scores, we imputed data and thus may have overestimated or underestimated risk. However, because coding for NIHSS scores has been added to ICD-10-CM and the documentation of NIHSS scores in clinical registries has increased in recent years, 6 missing NIHSS scores are projected to be less problematic in the future. Third, we capture NIHSS in the hospital where the patient is first admitted, consistent with the measure attributing the outcome of mortality to the admitting hospitals. However, if patients present first to an outside hospital for evaluation in the emergency department and are transferred before admission, the NIHSS will not reflect the initial stroke severity. However, to address this issue, we include a marker of ED transfer as a candidate risk factor for each of the measures. Despite these limitations, we used the best clinical data source available in the United States that includes both the NIHSS and a wide range of clinical factors, a validated and guideline-supported standardized stroke severity assessment, and engaged clinical experts and the public in development and review of the models.
Conclusions
We developed 3 outcome measures that produce estimates of hospital-level 30-day RSMRs for Medicare patients with ischemic stroke that can be used to assess hospital quality of care. All 3 measures incorporate the NIHSS as an assessment of stroke severity and are consistent with the consensus standards for publicly reported outcome measures. Each is a parsimonious risk model with good prediction of mortality. This new suite of stroke mortality measures provides flexibility with regard to implementing stroke mortality measurement that can evolve as CMS, providers, and payers transition from fully claims data-based measurement to EHR data-based measurement.
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